Edap TMS SA (EDAP)
5.30
+0.03
(+0.57%)
USD |
NASDAQ |
Jun 25, 16:00
5.30
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Gross Profit (TTM): 26.85M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 26.85M |
December 31, 2023 | 26.40M |
September 30, 2023 | 24.56M |
June 30, 2023 | 25.08M |
March 31, 2023 | 25.52M |
December 31, 2022 | 25.50M |
September 30, 2022 | 25.22M |
June 30, 2022 | 24.44M |
March 31, 2022 | 22.92M |
December 31, 2021 | 21.73M |
September 30, 2021 | 23.00M |
June 30, 2021 | 23.36M |
March 31, 2021 | 23.05M |
December 31, 2020 | 21.16M |
September 30, 2020 | 18.47M |
June 30, 2020 | 19.02M |
March 31, 2020 | 21.37M |
December 31, 2019 | 23.52M |
September 30, 2019 | 22.25M |
June 30, 2019 | 29.78M |
March 31, 2019 | 26.91M |
December 31, 2018 | 26.31M |
September 30, 2018 | 27.10M |
June 30, 2018 | 17.69M |
March 31, 2018 | 17.87M |
Date | Value |
---|---|
December 31, 2017 | 16.72M |
September 30, 2017 | 17.11M |
June 30, 2017 | 17.67M |
March 31, 2017 | 17.16M |
December 31, 2016 | 18.11M |
September 30, 2016 | 18.29M |
June 30, 2016 | 17.30M |
March 31, 2016 | 17.08M |
December 31, 2015 | 15.25M |
September 30, 2015 | 12.49M |
June 30, 2015 | 14.14M |
March 31, 2015 | 12.93M |
December 31, 2014 | 14.90M |
September 30, 2014 | 16.30M |
June 30, 2014 | 14.75M |
March 31, 2014 | 14.41M |
December 31, 2013 | 12.43M |
September 30, 2013 | 13.04M |
June 30, 2013 | 12.88M |
March 31, 2013 | 13.83M |
December 31, 2012 | 13.42M |
September 30, 2012 | 12.15M |
June 30, 2012 | 12.95M |
March 31, 2012 | 12.08M |
December 31, 2011 | 12.28M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
18.47M
Minimum
Sep 2020
29.78M
Maximum
Jun 2019
23.66M
Average
23.44M
Median
Gross Profit (TTM) Benchmarks
DBV Technologies SA | -- |
Cellectis SA | -- |
Genfit SA | -- |
Biodexa Pharmaceuticals Plc | -4.597M |
NuCana PLC | -- |